Supplementary Tables S1, S2 and Figures S1-S5 from A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III PIK3CA-Mutant ER-Positive and HER2-Negative Breast CancerCynthia X. Ma,Vera Suman,Matthew P. Goetz,Donald Northfelt,Mark E. Burkard,Foluso Ademuyiwa,Michael Naughton,Julie Margenthaler,Rebecca Aft,Richard Gray,Amye Tevaarwerk,Lee Wilke,Tufia Haddad,Timothy Moynihan,Charles Loprinzi,Tina Hieken,Erica K. Barnell,Zachary L. Skidmore,Yan-Yang Feng,Kilannin Krysiak,Jeremy Hoog,Zhanfang Guo,Leslie Nehring,Kari B. Wisinski,Elaine Mardis,Ian S. Hagemann,Kiran Vij,Souzan Sanati,Hussam Al-Kateb,Obi L. Griffith,Malachi Griffith,Laurence Doyle,Charles Erlichman,Matthew J. Ellisopenalex（2023）引用 0|浏览1关键词CancerAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
